FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2767987673> ?p ?o ?g. }

• W2767987673 endingPage "135" @default.
• W2767987673 startingPage "128" @default.
• W2767987673 abstract "OBJECTIVE To determine whether biomarkers of inflammation and endothelial dysfunction are associated with the development of kidney dysfunction and the time frame of their association. RESEARCH DESIGN AND METHODS Biomarkers were measured at four time points during 28 years of treatment and follow-up in patients with type 1 diabetes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) cohort. In addition to traditional biomarkers of inflammation (C-reactive protein and fibrinogen), we measured interleukin-6 (IL-6) and soluble tumor necrosis factor receptors 1 and 2 (sTNFR-1/2), markers of endothelial dysfunction (soluble intracellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin [sE-selectin]), and fibrinolysis (total and active plasminogen activator inhibitor-1 [PAI-1]). Renal outcomes were defined as progression to incident chronic kidney disease (stage 3 or more severe) or macroalbuminuria (albumin excretion rate ≥300 mg/24 h). Prospective multivariate event-time analyses were used to determine the association of each biomarker with each subsequent event within prespecified intervals (3-year and 10-year windows). RESULTS Multivariate event-time models indicated that several markers of inflammation (sTNFR-1/2), endothelial dysfunction (sE-selectin), and clotting/fibrinolysis (fibrinogen and PAI-1) are significantly associated with subsequent development of kidney dysfunction. Although some markers showed variations in the associations between the follow-up windows examined, the results indicate that biomarkers (sTNFR-1/2, sE-selectin, PAI-1, and fibrinogen) are associated with progression to chronic kidney disease in both the 3-year and the 10-year windows. CONCLUSIONS Plasma markers of inflammation, endothelial dysfunction, and clotting/fibrinolysis are associated with progression to kidney dysfunction in type 1 diabetes during both short-term and long-term follow-up." @default.
• W2767987673 created "2017-11-17" @default.
• W2767987673 creator A5015536406 @default.
• W2767987673 creator A5018547546 @default.
• W2767987673 creator A5019136419 @default.
• W2767987673 creator A5044243414 @default.
• W2767987673 creator A5046063952 @default.
• W2767987673 creator A5055665031 @default.
• W2767987673 creator A5064715409 @default.
• W2767987673 creator A5081151199 @default.
• W2767987673 date "2017-11-08" @default.
• W2767987673 modified "2023-10-16" @default.
• W2767987673 title "Association Between Inflammatory Markers and Progression to Kidney Dysfunction: Examining Different Assessment Windows in Patients With Type 1 Diabetes" @default.
• W2767987673 cites W1975768263 @default.
• W2767987673 cites W1985076127 @default.
• W2767987673 cites W1992026272 @default.
• W2767987673 cites W1998378885 @default.
• W2767987673 cites W1999188820 @default.
• W2767987673 cites W2007613360 @default.
• W2767987673 cites W2010261601 @default.
• W2767987673 cites W2011910330 @default.
• W2767987673 cites W2025362233 @default.
• W2767987673 cites W2029161580 @default.
• W2767987673 cites W2029774820 @default.
• W2767987673 cites W2042068980 @default.
• W2767987673 cites W2080919245 @default.
• W2767987673 cites W2082001761 @default.
• W2767987673 cites W2084084166 @default.
• W2767987673 cites W2090703892 @default.
• W2767987673 cites W2100697106 @default.
• W2767987673 cites W2104350567 @default.
• W2767987673 cites W2115034481 @default.
• W2767987673 cites W2126032465 @default.
• W2767987673 cites W2141495158 @default.
• W2767987673 cites W2151053450 @default.
• W2767987673 cites W2155965977 @default.
• W2767987673 cites W2607031541 @default.
• W2767987673 cites W2734011609 @default.
• W2767987673 cites W2769264260 @default.
• W2767987673 cites W4234637623 @default.
• W2767987673 cites W4256636055 @default.
• W2767987673 cites W4323238053 @default.
• W2767987673 doi "https://doi.org/10.2337/dc17-0867" @default.
• W2767987673 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5741153" @default.
• W2767987673 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29118060" @default.
• W2767987673 hasPublicationYear "2017" @default.
• W2767987673 type Work @default.
• W2767987673 sameAs 2767987673 @default.
• W2767987673 citedByCount "16" @default.
• W2767987673 countsByYear W27679876732018 @default.
• W2767987673 countsByYear W27679876732019 @default.
• W2767987673 countsByYear W27679876732020 @default.
• W2767987673 countsByYear W27679876732021 @default.
• W2767987673 countsByYear W27679876732022 @default.
• W2767987673 countsByYear W27679876732023 @default.
• W2767987673 crossrefType "journal-article" @default.
• W2767987673 hasAuthorship W2767987673A5015536406 @default.
• W2767987673 hasAuthorship W2767987673A5018547546 @default.
• W2767987673 hasAuthorship W2767987673A5019136419 @default.
• W2767987673 hasAuthorship W2767987673A5044243414 @default.
• W2767987673 hasAuthorship W2767987673A5046063952 @default.
• W2767987673 hasAuthorship W2767987673A5055665031 @default.
• W2767987673 hasAuthorship W2767987673A5064715409 @default.
• W2767987673 hasAuthorship W2767987673A5081151199 @default.
• W2767987673 hasBestOaLocation W27679876731 @default.
• W2767987673 hasConcept C126322002 @default.
• W2767987673 hasConcept C134018914 @default.
• W2767987673 hasConcept C188816634 @default.
• W2767987673 hasConcept C203014093 @default.
• W2767987673 hasConcept C2776825266 @default.
• W2767987673 hasConcept C2778653478 @default.
• W2767987673 hasConcept C2779036427 @default.
• W2767987673 hasConcept C2780972559 @default.
• W2767987673 hasConcept C555293320 @default.
• W2767987673 hasConcept C71924100 @default.
• W2767987673 hasConcept C90924648 @default.
• W2767987673 hasConceptScore W2767987673C126322002 @default.
• W2767987673 hasConceptScore W2767987673C134018914 @default.
• W2767987673 hasConceptScore W2767987673C188816634 @default.
• W2767987673 hasConceptScore W2767987673C203014093 @default.
• W2767987673 hasConceptScore W2767987673C2776825266 @default.
• W2767987673 hasConceptScore W2767987673C2778653478 @default.
• W2767987673 hasConceptScore W2767987673C2779036427 @default.
• W2767987673 hasConceptScore W2767987673C2780972559 @default.
• W2767987673 hasConceptScore W2767987673C555293320 @default.
• W2767987673 hasConceptScore W2767987673C71924100 @default.
• W2767987673 hasConceptScore W2767987673C90924648 @default.
• W2767987673 hasFunder F4320337357 @default.
• W2767987673 hasIssue "1" @default.
• W2767987673 hasLocation W27679876731 @default.
• W2767987673 hasLocation W27679876732 @default.
• W2767987673 hasLocation W27679876733 @default.
• W2767987673 hasLocation W27679876734 @default.
• W2767987673 hasOpenAccess W2767987673 @default.
• W2767987673 hasPrimaryLocation W27679876731 @default.
• W2767987673 hasRelatedWork W1966504330 @default.
• W2767987673 hasRelatedWork W1979139803 @default.
• W2767987673 hasRelatedWork W2030889776 @default.

• next